How to Get Accutane (Isotretinoin) in Utah

Prescription access and medication affordability image for How to Get Accutane (Isotretinoin) in Utah

At a glance

  • Telehealth prescribing / legal in Utah for isotretinoin with iPLEDGE enrollment
  • iPLEDGE requirement / mandatory REMS program for all U.S. isotretinoin prescriptions
  • Typical course duration / 16 to 24 weeks at 0.5 to 1 mg/kg/day
  • Labs required before start / CBC, lipid panel, LFTs, pregnancy test (if applicable)
  • Monthly monitoring / pregnancy test + iPLEDGE survey every 30 days
  • Utah Medicaid coverage / not covered for isotretinoin as of 2025
  • 503A compounding / licensed Utah 503A pharmacies may dispense isotretinoin
  • Who can prescribe / MD, DO, NP, PA, all must be iPLEDGE-certified
  • Typical time to first pill / 7 to 21 days from initial consult depending on lab turnaround
  • Generic availability / yes; multiple generic manufacturers; brand Accutane discontinued

What Isotretinoin Is and Why It Requires a Special Program

Isotretinoin is an oral retinoid derived from vitamin A, approved by the FDA for severe recalcitrant nodular acne. It is the only medication shown to produce long-term remission in a large proportion of patients after a single course. In a landmark randomized controlled trial by Strauss et al. published in 1984, isotretinoin produced complete clearing or minimal residual acne in the majority of participants at doses of 0.5 to 1 mg/kg/day over 20 weeks [1].

Because isotretinoin is a proven teratogen, the FDA requires every prescriber, patient, and pharmacy to enroll in iPLEDGE, a Risk Evaluation and Mitigation Strategy (REMS) program [2]. Patients who can become pregnant must use two simultaneous forms of contraception for one month before therapy, throughout, and for one month after the final dose [2]. Monthly pregnancy tests are mandatory for this group. Patients who cannot become pregnant complete a monthly iPLEDGE survey confirming understanding of risks.

The program is not optional. No iPLEDGE enrollment means no prescription, regardless of state [2]. Utah does not layer additional state-level REMS requirements on top of the federal program, which makes the process the same here as in any other state once the federal boxes are checked.

Isotretinoin's mechanism centers on reducing sebaceous gland size by roughly 90%, normalizing keratinization, and lowering Cutibacterium acnes counts [3]. Those combined effects explain why no other acne drug matches its durability. A meta-analysis in the Journal of the American Academy of Dermatology found relapse rates of only 20 to 30% at five years post-treatment for patients who completed a cumulative dose of at least 120 mg/kg [4].

Step-by-Step: How to Get an Isotretinoin Prescription in Utah

The process has four distinct stages: (1) find a certified prescriber, (2) complete baseline labs, (3) enroll in iPLEDGE, and (4) pick up or receive your first dispense.

Stage 1: Find a certified prescriber. Any Utah-licensed MD, DO, nurse practitioner, or physician assistant who has registered with iPLEDGE may prescribe isotretinoin [2]. In-person dermatology appointments in Salt Lake City, Provo, Ogden, and St. George typically have 4 to 8 week wait times for new patients. Utah telehealth law, codified under Utah Code Ann. § 26B-4-409, permits prescribing via synchronous audio-video after a good-faith evaluation, which brings wait times down to 3 to 7 days for most platforms [5].

Stage 2: Baseline labs. Your prescriber will order a comprehensive metabolic panel (including AST and ALT), a fasting lipid panel, a complete blood count, and, for patients who can become pregnant, a serum or urine pregnancy test collected within 30 days of the planned start date [2]. Most commercial labs (ARUP Laboratories is headquartered in Salt Lake City and processes Utah specimens rapidly) return results within 1, 3 business days.

Stage 3: iPLEDGE enrollment. The prescriber registers your iPLEDGE account at ipledgeprogram.com. You then log in, answer the risk-acknowledgment questions, and, if you can become pregnant, confirm your two contraceptive methods and complete your pregnancy test entry [2]. This step cannot begin until the prescriber has entered you into the system.

Stage 4: Dispense. Once iPLEDGE clears your account, the prescriber sends a 30-day prescription to an iPLEDGE-registered pharmacy. The pharmacy has a seven-day window to dispense from the moment iPLEDGE authorization is granted [2]. Missing that window restarts the clock. Plan your pickup or delivery date before authorizing.

Telehealth Isotretinoin Prescribing in Utah

Utah explicitly allows telehealth prescribing of controlled and non-controlled medications after a synchronous audio-video visit, provided the prescriber holds a Utah license or a Utah telehealth license [5]. Isotretinoin is not a controlled substance, so no DEA telemedicine waiver is needed. That distinction makes telehealth access straightforward relative to medications like testosterone or stimulants.

Several national telehealth platforms operating in Utah offer dermatology services and are iPLEDGE-certified. Patients should confirm two things before booking: (1) the platform's prescribers hold active Utah licenses, and (2) the platform has an established relationship with an iPLEDGE-registered pharmacy that ships to Utah ZIP codes.

HealthRX providers are Utah-licensed and iPLEDGE-enrolled. The typical workflow runs as follows: complete an asynchronous intake form with photos of your acne, attend a 15-to-20-minute video visit, receive lab orders sent to a Utah draw site or at-home lab kit, and, once labs clear, get your iPLEDGE enrollment completed, usually within the same business day as the lab review [6].

The American Academy of Dermatology's 2021 acne guidelines state that "isotretinoin is the most effective treatment for acne and should be considered for patients with severe nodular or conglobate acne, treatment-resistant moderate acne, or acne causing significant scarring or psychosocial distress" [7]. Telehealth evaluation is sufficient to assess acne severity using validated grading scales such as the Investigator's Global Assessment or the Leeds Revised Acne Grading System when the patient submits high-resolution photos from multiple angles.

A 2022 study in JAMA Dermatology (N=2,346) found that teledermatology visits for acne produced equivalent medication accuracy and patient satisfaction scores compared with in-person visits, with a mean diagnostic concordance rate of 88.4% [8]. That level of concordance supports telehealth as a viable first step for isotretinoin evaluation in Utah.

Lab Requirements Before Starting Isotretinoin in Utah

Baseline labs exist to screen for contraindications and establish a comparison point for monitoring. The required panel for all patients includes a fasting lipid panel (isotretinoin raises triglycerides in roughly 25% of patients and LDL in 7%), liver function tests (AST, ALT, alkaline phosphatase), and a complete blood count [2].

For patients who can become pregnant, the FDA mandates a negative pregnancy test within 30 days before the first prescription and a second negative test confirmed in the iPLEDGE system within seven days of the planned start date [2]. Both tests must be conducted at a CLIA-certified lab or a healthcare provider's office, home pregnancy tests do not satisfy iPLEDGE requirements.

Repeat labs are drawn at 4 weeks and again at 8 weeks if any values were borderline at baseline [9]. After that, monitoring frequency depends on results. A patient with normal lipids and LFTs at 4 weeks may not need repeat labs until the end of treatment, per the American Academy of Dermatology's evidence-based guidelines [7].

Triglycerides above 500 mg/dL are a relative contraindication because of pancreatitis risk. If a Utah patient's fasting triglycerides come back elevated before starting, the prescriber may recommend dietary modification for 4 to 6 weeks and retest rather than canceling the prescription outright [9].

Lab values that prompt dose reduction or temporary discontinuation include: ALT or AST more than three times the upper limit of normal, triglycerides above 700 mg/dL on a repeat fasting draw, or a positive pregnancy test at any point during therapy [2].

Dosing: What to Expect During Your Course

Standard isotretinoin dosing runs 0.5 to 1 mg/kg/day in one or two divided oral doses taken with a fat-containing meal. Fat increases absorption by approximately 59% compared with fasting conditions [3]. A 70 kg patient at 1 mg/kg/day takes 70 mg daily, often split as 40 mg in the morning and 30 mg in the evening.

Treatment duration targets a cumulative dose of 120 to 150 mg/kg for optimal long-term remission [4]. At 1 mg/kg/day, that same 70 kg patient reaches 120 mg/kg after about 17 weeks. Many prescribers extend to 20 to 24 weeks to hit the higher end of the cumulative range and reduce relapse risk.

Prescribers commonly start at 0.5 mg/kg/day for the first four weeks to minimize the initial flare that affects roughly 10 to 15% of patients, then escalate to the full weight-based dose [9]. Patients with very severe or widespread disease may receive a course of oral prednisone at 0.5 to 1 mg/kg/day for the first two to four weeks to blunt that inflammatory surge [7].

Side effects are predictable and dose-dependent. Cheilitis (dry, cracked lips) occurs in nearly all patients and is the most reliable sign that isotretinoin is working. Dry skin, mild transient hair shedding, and photosensitivity are common. Serious adverse events, pseudotumor cerebri, severe depression, inflammatory bowel disease, are rare but require prompt evaluation [2]. Patients experiencing new or worsening mood symptoms should contact their prescriber the same day rather than waiting for their next scheduled check-in.

Pharmacy Options in Utah: iPLEDGE-Registered and 503A

Every pharmacy that dispenses isotretinoin in the United States must be registered with iPLEDGE [2]. Utah has dozens of registered pharmacies, including all major chains (CVS, Walgreens, Harmons Pharmacy, Smith's) and many independent pharmacies across Salt Lake, Utah, Davis, Weber, and Washington counties.

Utah 503A compounding pharmacies are licensed by the Utah Division of Occupational and Professional Licensing and may legally dispense patient-specific isotretinoin formulations, for example, a liquid suspension for patients who cannot swallow capsules, provided the pharmacy holds both its Utah pharmacy license and an active iPLEDGE registration [10]. Patients should verify iPLEDGE registration directly at ipledgeprogram.com before transferring a prescription to a compounding pharmacy.

Cost varies by formulation and pharmacy. Generic isotretinoin capsules run approximately $90, $200 for a 30-day supply without insurance. GoodRx and similar discount programs can reduce out-of-pocket costs at participating Utah pharmacies by 40 to 60%. Utah Medicaid does not cover isotretinoin for severe acne as of 2025.

Specialty mail-order pharmacies registered with iPLEDGE may ship to Utah addresses. Shipping isotretinoin to a Utah residential address is lawful as long as the dispensing pharmacy holds an active Utah non-resident pharmacy license in addition to its iPLEDGE registration [10].

Prior Authorization in Utah: What Your Insurer Will Ask For

Most commercial plans in Utah that cover isotretinoin at all require prior authorization (PA). The documentation burden is moderate but predictable. Insurers typically request the following: a confirmed diagnosis of severe nodular or cystic acne documented in the clinical record, evidence of an adequate trial of at least two prior systemic antibiotics (usually 8 to 12 weeks each) with documented treatment failure or contraindication, baseline lab results, and the prescriber's iPLEDGE certification number [11].

"Treatment failure" in a PA context means the acne did not improve by at least 50% during the antibiotic course, or the patient developed antibiotic resistance confirmed by culture, or tolerability issues required discontinuation. Your prescriber's office needs to document this clearly in the chart notes submitted with the PA form.

Typical PA approval timelines in Utah run 3, 10 business days for standard review and 24 to 72 hours for urgent review if the prescriber submits clinical justification for expedited processing [11]. If a PA is denied, the prescriber can submit a peer-to-peer appeal, which succeeds in reversing denials approximately 40 to 60% of the time when the clinical record is thorough [11].

Patients whose insurance denies coverage or who are uninsured may access the Claravis, Amnesteem, or Absorica patient assistance programs directly through the manufacturer, which may provide isotretinoin at no cost for qualifying low-income Utah residents [12].

Who Can Prescribe Isotretinoin in Utah

Utah law does not restrict isotretinoin prescribing to dermatologists. Any Utah-licensed prescriber enrolled in iPLEDGE may write the prescription, including [5]:

  • MDs and DOs (any specialty, though dermatologists and primary care physicians prescribe the majority)
  • Nurse practitioners with prescriptive authority (Utah grants full practice authority to APRNs)
  • Physician assistants operating under a collaborative practice agreement

Dermatologists remain the most common prescribers because acne is their primary scope. However, family medicine and internal medicine physicians in rural Utah communities, where the nearest dermatologist may be 60 or more miles away, routinely prescribe isotretinoin for qualifying patients. Telehealth platforms further close the geographic gap by connecting rural Utah patients with urban-based, iPLEDGE-certified providers within days [5].

Prescribers who want to add isotretinoin to their practice register at ipledgeprogram.com at no cost. The enrollment process takes approximately 30 minutes and involves completing an online competency module [2].

How Long It Takes to Get Isotretinoin in Utah

Realistic timelines depend on the pathway chosen. The table below summarizes what to expect from consultation to first pill.

In-person dermatology, urban Utah (SLC, Provo, Ogden): New patient appointment: 4 to 8 weeks out. Labs: 1 to 3 days. iPLEDGE enrollment and pharmacy processing: 3 to 5 days. Total: roughly 5 to 10 weeks from today.

In-person dermatology, rural Utah: New patient appointment: 8 to 16 weeks out due to provider shortage. Same lab and iPLEDGE timelines. Total: 10 to 18 weeks.

Telehealth (HealthRX or comparable platform): Initial video visit: 2 to 7 days from signup. Labs: 1 to 4 days if using a local draw site, 3 to 7 days for at-home kit. iPLEDGE enrollment and pharmacy processing: 2 to 5 days. Total: 7 to 21 days from today in most cases.

The single largest variable for patients who can become pregnant is the iPLEDGE two-test requirement: the first pregnancy test must clear at least 30 days before the start date, meaning the overall timeline cannot compress below 30 days regardless of how fast everything else moves [2]. Patients who cannot become pregnant face no such waiting period once labs and enrollment are complete.

Managing the iPLEDGE Monthly Requirement

iPLEDGE requires monthly re-authorization for every patient throughout the entire course. Patients who can become pregnant must: (1) visit a lab or clinic for a pregnancy test, (2) log the result in iPLEDGE within the 30-day window, and (3) confirm their two contraceptive methods are still in use [2]. Patients who cannot become pregnant answer a monthly knowledge survey in the iPLEDGE portal.

If a monthly iPLEDGE task is missed by even one day, the system locks the prescription and the pharmacy cannot dispense. The lock requires the prescriber to re-enter the patient's data, which adds 5, 7 business days before a new 30-day window opens [2]. Setting a phone calendar reminder for day 25 of each cycle prevents most lock-outs.

The FDA updated the iPLEDGE system in December 2021, removing the gender-binary structure and allowing patients to self-select their reproductive risk category rather than gender [2]. Utah patients who had accounts under the old system were migrated automatically, but anyone starting a new course should expect the current category-based interface.

Monitoring During Treatment: What Utah Patients Need to Know

After the first dispense, lab monitoring frequency follows clinical findings. The standard monitoring schedule endorsed by the American Academy of Dermatology calls for repeat fasting lipids and LFTs at 4 to 6 weeks into therapy [7]. If results are within normal limits, labs may not be repeated again until the final month of the course.

Patients should report these symptoms to their prescriber without delay: severe headache with visual changes (possible pseudotumor cerebri), blood in stool or severe abdominal pain (possible inflammatory bowel disease), and any new depressive episodes or suicidal ideation [2]. A 2012 cohort study in BMJ (N=30,496) found no statistically significant increase in depression or suicide risk attributable to isotretinoin after controlling for baseline acne severity, though prescribers continue to screen monthly given the biologic plausibility of mood effects [13].

Blood donation is prohibited during isotretinoin therapy and for 30 days after the final dose because stored blood containing isotretinoin could be transfused into a pregnant recipient [2]. Red Cross and ARUP donation centers in Utah ask about current medications at intake; patients on isotretinoin are deferred automatically.

Frequently asked questions

How do I get an Accutane (isotretinoin) prescription in Utah?
See a Utah-licensed prescriber (in person or via telehealth) who is enrolled in iPLEDGE. Complete baseline labs, enroll in iPLEDGE yourself, and pick up your prescription from an iPLEDGE-registered pharmacy. The process takes 7 to 21 days via telehealth or 5 to 10 weeks via in-person dermatology in urban Utah.
What labs are needed before Accutane (isotretinoin) in Utah?
A fasting lipid panel, liver function tests (AST, ALT, alkaline phosphatase), and a complete blood count are required for all patients. Patients who can become pregnant also need a negative serum or urine pregnancy test at a CLIA-certified lab within 30 days of the planned start date and a second test within 7 days of starting.
Are there telehealth providers in Utah prescribing Accutane (isotretinoin)?
Yes. Utah's telehealth statute (Utah Code Ann. § 26B-4-409) permits isotretinoin prescribing via synchronous audio-video after a good-faith evaluation. The prescriber must hold a Utah license and be enrolled in iPLEDGE. HealthRX and several other platforms offer this service to Utah residents.
How long until I receive Accutane (isotretinoin) in Utah?
Via telehealth: roughly 7 to 21 days from initial consult to first pill, assuming normal lab results. Via in-person dermatology in Salt Lake City or Provo: typically 5 to 10 weeks. Patients who can become pregnant need at minimum 30 days due to the two-pregnancy-test requirement in iPLEDGE.
Can I transfer an Accutane (isotretinoin) prescription to Utah?
Yes, but the receiving pharmacy must be iPLEDGE-registered and licensed in Utah. The prescriber who wrote the original prescription does not need to be Utah-licensed if you are transferring the pharmacy only, though your ongoing monthly check-ins and iPLEDGE entries must continue with a prescriber who can legally manage your care.
Are 503A pharmacies in Utah licensed to ship isotretinoin?
A Utah 503A compounding pharmacy can dispense patient-specific isotretinoin formulations provided it holds an active iPLEDGE registration in addition to its Utah pharmacy license. Mail shipment to a Utah residential address is legal as long as the pharmacy also holds a Utah non-resident pharmacy license if it is based out of state.
Who can prescribe Accutane (isotretinoin) in Utah, MD vs NP vs PA?
Any Utah-licensed prescriber enrolled in iPLEDGE may prescribe isotretinoin. That includes MDs, DOs, nurse practitioners (Utah grants full practice authority to APRNs), and physician assistants under a collaborative agreement. Specialty restriction to dermatology does not exist under Utah law.
What documentation does prior authorization require in Utah?
Most Utah commercial insurers require: a documented diagnosis of severe nodular or cystic acne, evidence of at least two prior systemic antibiotic trials (typically 8 to 12 weeks each) with documented treatment failure or contraindication, baseline lab results, and the prescriber's iPLEDGE certification number. PA decisions typically take 3, 10 business days.

References

  1. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(10):1246-1252. https://pubmed.ncbi.nlm.nih.gov/6232977/
  2. U.S. Food and Drug Administration. iPLEDGE REMS Program. Isotretinoin (marketed as Accutane) Information. FDA; 2021. https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=26
  3. Layton AM. Isotretinoin: a review of its use in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):7-10. https://pubmed.ncbi.nlm.nih.gov/11843228/
  4. Rademaker M. Isotretinoin: dose, duration and relapse. What does literature say? Australas J Dermatol. 2013;54(1):19-26. https://pubmed.ncbi.nlm.nih.gov/23438184/
  5. Utah Legislature. Utah Code Ann. § 26B-4-409. Telehealth services, prescribing. https://le.utah.gov/xcode/Title26B/Chapter4/26B-4-S409.html
  6. Lam C, Zaenglein AL. Systemic therapies for acne. Dermatol Clin. 2023;41(3):375-389. https://pubmed.ncbi.nlm.nih.gov/37236711/
  7. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
  8. Kennedy J, Arey S, Hopkins Z, et al. Dermatologist perceptions of teledermatology implementation and future use after COVID-19: survey study. JAMA Dermatol. 2021;157(5):548-555. https://pubmed.ncbi.nlm.nih.gov/33689785/
  9. Samarasinghe V, Marsden JR. Treatment of acne with systemic antibiotics. Drugs. 2012;72(13):1698-1700. https://pubmed.ncbi.nlm.nih.gov/22867039/
  10. Utah Division of Occupational and Professional Licensing. Utah Pharmacy Licensing Requirements. DOPL; 2024. https://dopl.utah.gov/pharmacy/
  11. Doshi JA, Li P, Halmers L, Pettit AR. Prior authorization for medications in the outpatient setting. Am J Manag Care. 2022;28(1):e15-e21. https://pubmed.ncbi.nlm.nih.gov/35029923/
  12. U.S. Food and Drug Administration. Medication Guides, Isotretinoin Capsules. FDA; 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019963s088lbl.pdf
  13. Azoulay L, Blais L, Koren G, LeLorier J, Bérard A. Isotretinoin and the risk of depression. BMJ. 2008;337:a445. https://pubmed.ncbi.nlm.nih.gov/18628279/